GSK Plc agreed on a partnership deal worth as much as $650 million with US biotech Vesalius Therapeutics to help advance drug ...

GSK is paying $80 million to ink a multi-target neurodegenerative pact with Flagship-founded Vesalius Therapeutics that ...

When Hurricane Milton caused the rare cancelation of the American Health Care Association/National Center for Assisted Living ...

There’s still a lot we don’t know about how Parkinson’s disease develops. But one lifestyle intervention already has strong evidence behind it.

Vesalius Therapeutics, a company pioneering a revolutionary platform to deliver breakthrough treatments for common diseases, ...

A team of researchers from the University of Barcelona and the Bellvitge Biomedical Research Institute (IDIBELL) has ...

Two recent chemistry studies pinpoint reactions that may link the gut microbiome to the development of Parkinson's disease.

Former top US nursing home spokesman Mark Parkinson has released his first book, a "playbook" for achieving clinical and ...

Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.

From this you can see that Virtually Parkinson was never intended to replace a host but to be an experiment in interaction ...

Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...

The Parkinson’s Group, Glenvista Chapter held their year-end function on November 9 at the Renaissance Retirement Village. The function was a great success, a large spread as well as a great turnout ...